**Question:** Best indicator of Ovarian reserve:

A. Anti-Mullerian hormone (AMH)
B. Antral follicle count (AFC)
C. Follicle-stimulating hormone (FSH)
D. Luteinizing hormone (LH)

**Correct Answer:**

A. Anti-Mullerian hormone (AMH)

**Core Concept:** Ovarian reserve refers to the number and quality of remaining follicles in a woman's ovaries, which is crucial for assessing fertility potential and guiding reproductive treatments. Antral follicle count (AFC), FSH, LH, and AMH are used as indicators of ovarian reserve, but AMH stands out for its superiority.

**Why the Correct Answer is Right:**

AMH is produced by granulosa cells surrounding small antral follicles in the ovaries. It is considered the most reliable indicator of ovarian reserve as it remains stable throughout the menstrual cycle and is less affected by age, compared to FSH and LH. AMH levels decrease with decreased ovarian reserve, making it a valuable tool for assessing fertility potential and guiding reproductive treatments, such as in in vitro fertilization (IVF) and gonadotropin-releasing hormone (GnRH) analog therapy.

**Why Each Wrong Option is Incorrect:**

**B. Antral follicle count (AFC):** AFC is an indirect measure of ovarian reserve, counting the number of small follicles in the ovaries. Although it's a quantitative approach, it is influenced by factors like age, obesity, and ovarian stimulation, making it less reliable compared to AMH.

**C. Follicle-stimulating hormone (FSH):** FSH is essential for stimulating follicle growth, and increased levels indicate decreased ovarian reserve. However, FSH levels fluctuate throughout the menstrual cycle, making it less accurate than AMH.

**D. Luteinizing hormone (LH):** LH assists in follicle maturation, and elevated levels indicate decreased ovarian reserve. However, LH levels are also influenced by the menstrual cycle phase, similar to FSH.

**Clinical Pearl:**

AMH is a valuable tool for assessing ovarian reserve and guiding reproductive treatments, particularly in cases of diminished ovarian reserve or premature ovarian insufficiency. Regular monitoring of AMH levels helps in determining the optimal time for IVF treatment initiation and adjusting the dosage of GnRH analog therapy. This information is crucial for clinical practice, as it enables healthcare professionals to provide personalized treatment strategies tailored to each patient's specific ovarian reserve status.